Eight weeks after surgery, she has full range of motion, she’s bench pressing more than she did before the injury, and she’s completely pain-free. Then she reaches into the back seat for a bag of groceries and something in her shoulder gives out again.
Sound familiar? It should. This is one of the more frustrating patterns in manual and movement therapy: the client who tests strong, feels great, and still reinjures the same tissue. It’s not because she skipped her home exercises, and it’s probably not something you missed in your assessment.
It’s because muscle and connective tissue don’t heal on the same schedule. Nobody told her tendon that her muscles were ready.
Two Tissues, Different Clocks
Here’s the assumption most people walk in with: collagen just turns over slower than muscle protein, end of story, give it time and it’ll catch up.
The isotope data tell a different story.
Researchers who measured postabsorptive collagen synthesis rates in human tendon, ligament, and muscle using stable isotope infusion found tendon and ligament producing new collagen at roughly 0.04–0.046% per hour – comparable to, and if anything a touch faster than, mixed muscle protein turnover.(1) A separate multi-tissue study using the same method found synthesis rates across tendon, cartilage, ligament and bone weren’t significantly different from muscle at all.(2)
So fibroblasts aren’t dragging their feet. They’re producing new collagen at a completely reasonable clip.
What’s actually different is how much of that new collagen sticks around as a usable structure. Radiocarbon dating, using the atmospheric carbon-14 spike from mid-century bomb testing, has shown the collagen sitting at the core of a mature tendon barely changes for the rest of a person’s life.(3) Most of what gets synthesized nearby is degraded rather than built in.
Collagen half-life across musculoskeletal tissue lands somewhere around two to five months. The factory keeps running. The building it’s meant to be reinforcing just doesn’t update nearly as often.
Why the Structural Timeline Lags?
Some of this comes down to plumbing. Tendon is comparatively hypovascular and hypocellular next to skeletal muscle – fewer vessels, fewer cells doing the work – which slows how quickly nutrients, signaling molecules and repair cells actually arrive on site.(4) It’s a large part of why a tendon injury drags on longer than a muscle strain of similar severity.
Some of it is simply what the tissue is built for. Tendon’s dense, low-cellularity matrix exists to transfer tensile load with almost no give, not to bulk up the way muscle does across a training cycle.
One widely cited review of loading and tendon adaptation put it bluntly: the adaptation time to chronic loading is longer in tendon than in the contractile elements of muscle, and it takes considerably more prolonged loading before measurable changes in tendon size or mechanical properties appear.(5)
Load Is the Signal, Not Rest
None of this is an argument for backing off. If anything, it’s the opposite.
Tenocytes read mechanical load through integrins and focal adhesion complexes, which switch on the signaling cascades behind matrix remodeling. Take the load away and you don’t get a neutral pause – you get a step backward. In one study, de-tensioning engineered human tendon tissue disrupted its architecture and drove up pro-inflammatory markers within days.(6)
Progressive load is the actual stimulus this tissue responds to. Not immobilization. Not just waiting it out. That’s the whole logic behind the isometric and slow, heavy-loading protocols that have become standard in tendinopathy rehab.
Reading the Gap in Practice
This is exactly where pacing decisions matter and where the data get uncomfortable.
In one prospective cohort, young athletes who returned to sport before 9 months after ACL reconstruction had roughly seven times the rate of second injury compared with those who waited longer.(7) Seven times. And that held even when their strength symmetry testing looked fine at the time of return.
A separate systematic review of human ACL graft biopsies found the graft didn’t resemble native ligament tissue histologically until somewhere between 12 and 24 months out.(8) Strength testing was never going to catch that.
Muscle performance and pain-free range of motion tell you something real. They just don’t tell you where the connective tissue actually sits on its own remodeling curve, and that’s the piece manual and movement therapists are uniquely positioned to keep watching. It’s also the physiology sitting underneath the broader category of supplements for bone and joint health that clients bring up constantly, worth knowing what that evidence actually supports before the conversation happens.
Nutritional Support, With the Caveats Attached
The evidence here is real, but it’s modest, and it deserves to be described that way rather than dressed up.
In a randomized crossover trial, participants who took 15 g of vitamin C–enriched gelatin an hour before intermittent exercise – that trial’s specific protocol, not a dosing recommendation – showed roughly double the blood marker for collagen synthesis compared with placebo. Serum from those same participants also improved mechanical properties in an engineered-ligament model.(9) That’s genuinely interesting, dose-timed, mechanistic evidence – from a small trial. It’s not proof that anyone’s injury risk actually dropped.
A separate small trial looked at postoperative vitamin C injections in flexor tendon repair. Range-of-motion and outcome scores trended better in the treatment group, but the difference didn’t reach statistical significance against standard care.(10)
People also ask, often in the same breath, whether collagen or calcium matters more for joint and bone support. Fair question, and the honest answer depends entirely on which tissue and which outcome is being asked about: is collagen or calcium better for bones?
The Practical Takeaway
Muscle and connective tissue are running on two different clocks, and that’s not a training failure anyone needs to address. It’s biology asking for patience.
Pace the return to load by tissue readiness, not by how strong or pain-free someone feels. That’s usually the difference between a client who stays recovered and one who’s back on your table within months.
Byline: Laura Kraujalyte (karolinab@theimpactbrands.com)
References
- Babraj JA, et al. Collagen synthesis in human musculoskeletal tissues and skin. Am J Physiol Endocrinol Metab. 2005. https://journals.physiology.org/doi/full/10.1152/ajpendo.00243.2005
- Smeets JSJ, et al. Protein synthesis rates of muscle, tendon, ligament, cartilage, and bone tissue in vivo in humans. PLOS ONE. 2019. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0224745
- Tendon Cell Biology: Effect of Mechanical Loading. Cell Physiol Biochem. 2024. https://www.cellphysiolbiochem.com/Articles/000743/index.html
- Advances in non-coding RNA in tendon injuries. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11148651/
- Kjaer M, et al. From mechanical loading to collagen synthesis, structural changes and function in human tendon. Scand J Med Sci Sports. 2009. https://pubmed.ncbi.nlm.nih.gov/19706001/
- Release of Tensile Strain on Engineered Human Tendon Tissue Disturbs Cell Adhesions, Changes Matrix Architecture, and Induces an Inflammatory Phenotype. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC3897642/
- Beischer S, et al., JOSPT 2020. Young Athletes Who Return to Sport Before 9 Months After ACL Reconstruction Have a Rate of New Injury 7 Times That of Those Who Delay Return. J Orthop Sports Phys Ther. https://www.jospt.org/doi/10.2519/jospt.2020.9071
- Claes S, Verdonk P, Forsyth R, Bellemans J. The “Ligamentization” Process in Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2011. https://journals.sagepub.com/doi/abs/10.1177/0363546511402662
- Shaw G, et al. Vitamin C–enriched gelatin supplementation before intermittent activity augments collagen synthesis. Am J Clin Nutr. 2017. https://ajcn.nutrition.org/article/S0002-9165(22)04723-2/fulltext
- Effect of Vitamin C Injection on Flexor Tendon Healing in Zone II: A Randomized Controlled Trial. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12925623/
